DRUG-INTERACTIONS WITH DIGOXIN

被引：30

作者：

BROWN, DD ^{[1
]}

SPECTOR, R ^{[1
]}

JUHL, RP ^{[1
]}

机构：

[1] UNIV PITTSBURGH, DEPT PHARM PRACTICE, PITTSBURGH, PA 15260 USA

来源：

关键词：

D O I：

10.2165/00003495-198020030-00003

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：198 / 206

页数：9

共 54 条

[1] ALBERT KS, 1978, J PHARM SCI, V1, P1582
[2] BEERMANN B, 1973, ACTA MED SCAND, P293
[3] ABSORPTION OF ORALLY ADMINISTERED [12 ALPHA-H-3 ]DIGOXIN IN MAN
BEERMANN, B
HELLSTROM, K
ROSEN, A
[J]. CLINICAL SCIENCE, 1972, 43 (04) : 507 - +
[4] BINNION PF, 1974, CLIN PHARMACOL THER, V16, P807
[5] DRUG INTERACTIONS WITH DIGITALIS GLYCOSIDES
BINNION, PF
[J]. DRUGS, 1978, 15 (05) : 369 - 380
[6] TRITIATED DIGOXIN .19. TURNOVER STUDIES IN DIABETES-INSIPIDUS
BISSETT, JK
DOHERTY, JE
FLANIGAN, WJ
DALRYMPLE, GV
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1973, 31 (03) : 327 - 330
[7] BROWN DD, 1979, CLIN RES, V27, pA610
[8] BROWN DD, 1976, CLIN PHARMACOL THER, V20, P395
[9] DECREASED BIOAVAILABILITY OF DIGOXIN DUE TO ANTACIDS AND KAOLIN-PECTIN
BROWN, DD
JUHL, RP
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (19) : 1034 - 1037
[10] DECREASED BIOAVAILABILITY OF DIGOXIN DUE TO HYPOCHOLESTEROLEMIC INTERVENTIONS
BROWN, DD
JUHL, RP
WARNER, SL
[J]. CIRCULATION, 1978, 58 (01) : 164 - 172